CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CYTR's Net Income Growth by Quarter and Year

Cytrx's Net Income results by quarter and year




CYTR Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -2.34 -4.46 -7.67
III Quarter September -1.47 -3.29 -5.12 -12.18
II Quarter June -1.27 -3.01 -14.36 -18.28
I Quarter March -1.43 -4.08 -11.04 -12.64
FY   -4.17 -12.72 -34.98 -50.77



CYTR Net Income third quarter 2019 Y/Y Growth Comment
Cytrx Corp in the third quarter recorded net loss of $ -1.47 millions.

According to the results reported in the third quarter, Cytrx Corp achieved the best Net Income growth in Biotechnology & Drugs industry. While Cytrx Corp' s Net Income no change of % ranks overall at the positon no. in the third quarter.




CYTR Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cytrx's third quarter 2019 Net Income $ -1.47 millions CYTR's Income Statement
Cytrx's third quarter 2018 Net Income $ -3.29 millions Quarterly CYTR's Income Statement
New: More CYTR's historic Net Income Growth >>


CYTR Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cytrx's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYTR's III. Quarter Q/Q Net Income Comment
Recent net loss of -1.47 millions by Cytrx Corp come out even worse considering the net loss -1.27 millions in the previous quarter.

Within Biotechnology & Drugs industry Cytrx Corp achieved highest sequential Net Income growth. While Cytrx's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYTR's III. Quarter Q/Q Net Income Comment
Recent accomplishment of -1.47 millions by Cytrx Corp look even less good if you take a look at -1.27 millions a quarter before.

Within Biotechnology & Drugs industry Cytrx Corp achieved highest sequential Net Income growth. While Cytrx's Net Income growth quarter on quarter, overall rank is .


Cytrx's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ -6.51 $ -8.33 $ -10.06 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Cytrx Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Cytrx Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CYTR's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CYTR's Competitors
Net Income Growth for Cytrx's Suppliers
Net Income Growth for CYTR's Customers

You may also want to know
CYTR's Annual Growth Rates CYTR's Profitability Ratios CYTR's Asset Turnover Ratio CYTR's Dividend Growth
CYTR's Roe CYTR's Valuation Ratios CYTR's Financial Strength Ratios CYTR's Dividend Payout Ratio
CYTR's Roa CYTR's Inventory Turnover Ratio CYTR's Growth Rates CYTR's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2019
Quest Diagnostics Inc -0.44 %$ -0.441 millions
Dexcom, Inc. -1.72 %$ -1.717 millions
Merck & Co., Inc. -2.60 %$ -2.605 millions
Procyon Corp -3.94 %$ -3.941 millions
Innoviva, inc. -6.21 %$ -6.211 millions
Radnet, Inc. -11.80 %$ -11.796 millions
Masimo Corp -14.08 %$ -14.076 millions
Hca Healthcare, Inc. -14.73 %$ -14.732 millions
Bio-techne Corp -17.27 %$ -17.267 millions
Pro Dex Inc -18.16 %$ -18.162 millions
Stryker Corp -21.02 %$ -21.017 millions
Zynex Inc -21.54 %$ -21.536 millions
Magellan Health, inc. -21.63 %$ -21.628 millions
Ani Pharmaceuticals Inc -22.67 %$ -22.672 millions
Exelixis, Inc. -23.04 %$ -23.042 millions
Bristol Myers Squibb Co -28.56 %$ -28.556 millions
Healthcare Services Group Inc -29.68 %$ -29.679 millions
Laboratory Corp Of America Holdings -30.72 %$ -30.721 millions
Nuvasive Inc -30.85 %$ -30.855 millions
Jazz Pharmaceuticals Plc -31.50 %$ -31.504 millions
Standard Diversified Inc. -36.36 %$ -36.364 millions
Petmed Express Inc -38.01 %$ -38.012 millions
Techcare Corp. -38.18 %$ -38.184 millions
Amphastar Pharmaceuticals, Inc. -39.11 %$ -39.109 millions
Universal Health Services Inc -42.32 %$ -42.321 millions
Tivity Health, Inc. -45.10 %$ -45.104 millions
Utah Medical Products Inc -45.21 %$ -45.209 millions
Jrsis Health Care Corp -46.24 %$ -46.238 millions
Psychemedics Corp -46.90 %$ -46.902 millions
Biotelemetry, Inc. -48.23 %$ -48.234 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ULNV's Profile

Stock Price

ULNV's Financials

Business Description

Fundamentals

Charts & Quotes

ULNV's News

Suppliers

ULNV's Competitors

Customers & Markets

Economic Indicators

ULNV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071